Recent media coverage of biomedical engineers who have designed a synthetic yeast genome, resequencing the yeast DNA in the process to eliminate redundancy and reduce its size, has briefly brought to public attention a gamut of issues about the preparedness of scientific regulators for the pace of scientific advances.